Table 2.
Bacterial HAIs in ICU and non-ICU settings at UHK
| Bacterial HAIs | ICU | Non-ICU | ||
|---|---|---|---|---|
| N | % | N | % | |
| PNA | 103 | 46.2 | 7 | 10.1 |
| UTI | 73 | 33.0 | 48 | 69.9 |
| BSI | 41 | 18.8 | 9 | 13.2 |
| Others | 6 | 3.8 | 5 | 7.2 |
| Total | 223 | 100.0 | 69 | 100.0 |
| Bacterial HAI, incidence % | 13.8% | 5.7% | ||
| Bacterial HAI, incidence, per 1000pds | 11.9 | 3.0 | ||
| XDR prevalence** | % | % | ||
| PNA | 39 | 27.5 | 1 | 12.5 |
| UTI | 19 | 20.7 | 8 | 14.3 |
| BSI | 6 | 12.8 | 1 | 10.0 |
| Others | 1 | 14.3 | 2 | 28.0 |
| Total | 65 | 22.6 | 12 | 14.8 |
| Prevalence of specific resistance mechanisms | % | % | ||
| MRSA, N = 6 | 13% | 40% | ||
| VRE, N = 16 | 26% | 25% | ||
| KPC, N = 5 | 10% | 14% | ||
| OXA-48, N = 1 | 2% | 0.0% | ||
| MBL*, N = 0 | 0.0% | 0.0% | ||
| CR-A. baumannii, N = 52 | 93% | 0.0% | ||
| Incidence rate of specific resistance mechanisms | per 10,000 hospitalizations | per 10,000 hospitalizations | ||
| CR Enterobacteriaceae | 37.2 | 8.3 | ||
| CR A. baumannii | 359.7 | 8.3 | ||
Legend: BSI: bloodstream infection; CR: carbapenem resistance; HAI: healthcare-associated infections; ICU: intensive care unit; KPC: Klebsiella pneumoniae carbapenemase (KPC)-producing bacteria; MBL: metallo-β-lactamase; MRSA: methicillin-resistant Staphylococcus aureus; OXA-48: OXA-48-type carbapenemases; pds: patient days; PNA: pneumonia; UTI: urinary tract infection; VRE: Vancomycin-resistant Enterococcus; XDR: extensively drug-resistant; UHK: University Hospital in Krakow
*Evaluated only for E. coli, K. pneumoniae
**Calculated as: (No of XDR-HAI/all HAIs) *100